Evaluation of the safety and efficacy of pathotropic nanoparticles bearing a dominant negative cyclin G1 construct for chemoresistant osteosarcoma and other sarcomas: Phase I, II, and III studies
Year: 2009
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: University of Maryland, Baltimore, Sarcoma Oncology Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2587701010
